Prab: CSV import

2025-02-15T11:00:25Z

CSV import

@@ Line 1: / Line 1: @@
-'''Protegrin''' is a type of [[antimicrobial peptide]] that is found in [[porcine]] (pig) leukocytes. It is part of the [[cathelicidin]] family of peptides, which are known for their broad-spectrum antimicrobial activity. Protegrin was first discovered in the 1990s and has since been studied for its potential use in treating [[bacterial infection]]s, including those that are resistant to traditional [[antibiotics]].
+== Protegrin ==
-==Structure==
+[[File:Protegrin_structures.png|thumb|right|300px|Structures of various protegrins.]]
-==Mechanism of Action==
+'''Protegrins''' are a class of [[antimicrobial peptides]] that are part of the innate immune system in mammals. These peptides are known for their broad-spectrum [[antimicrobial activity]] against [[bacteria]], [[fungi]], and [[viruses]]. Protegrins are particularly noted for their ability to disrupt microbial membranes, leading to cell death.
-==Potential Therapeutic Uses==
+== Structure ==
-==Challenges and Future Directions==
+Protegrins are small peptides, typically consisting of 16 to 18 [[amino acids]]. They are characterized by a high content of [[arginine]] and [[cysteine]] residues, which form disulfide bonds that stabilize their [[beta-sheet]] structure. This structure is crucial for their function, as it allows them to insert into and disrupt microbial membranes.
-While protegrin has shown promise as a potential antimicrobial agent, there are several challenges that must be overcome before it can be used clinically. One of the main challenges is its toxicity to mammalian cells, which limits its therapeutic window. Additionally, protegrin is susceptible to proteolytic degradation, which can reduce its effectiveness. Future research will need to focus on overcoming these challenges, potentially through the development of protegrin analogs or delivery systems that can increase its stability and reduce its toxicity.
 [[Category:Antimicrobial peptides]]

Prab: CSV import

2024-02-25T08:47:36Z

CSV import

New page

'''Protegrin''' is a type of [[antimicrobial peptide]] that is found in [[porcine]] (pig) leukocytes. It is part of the [[cathelicidin]] family of peptides, which are known for their broad-spectrum antimicrobial activity. Protegrin was first discovered in the 1990s and has since been studied for its potential use in treating [[bacterial infection]]s, including those that are resistant to traditional [[antibiotics]].

==Structure==
Protegrin is a small, cationic peptide that is composed of 18 amino acids. It has a beta-hairpin structure, which is stabilized by two disulfide bonds. This structure allows protegrin to interact with the negatively charged components of bacterial cell membranes, leading to cell lysis and death.

==Mechanism of Action==
Protegrin exerts its antimicrobial effects by disrupting the integrity of bacterial cell membranes. It is thought to do this by forming pores in the membrane, which leads to a loss of membrane potential and ultimately cell death. This mechanism of action is different from that of traditional antibiotics, which typically inhibit specific bacterial enzymes or processes.

==Potential Therapeutic Uses==
Due to its broad-spectrum antimicrobial activity, protegrin has been studied for its potential use in treating a variety of bacterial infections. It has shown promise in preclinical studies for treating infections caused by [[Gram-positive bacteria]], [[Gram-negative bacteria]], and [[fungi]]. Additionally, because of its unique mechanism of action, protegrin may be useful in treating infections that are resistant to traditional antibiotics.

==Challenges and Future Directions==
While protegrin has shown promise as a potential antimicrobial agent, there are several challenges that must be overcome before it can be used clinically. One of the main challenges is its toxicity to mammalian cells, which limits its therapeutic window. Additionally, protegrin is susceptible to proteolytic degradation, which can reduce its effectiveness. Future research will need to focus on overcoming these challenges, potentially through the development of protegrin analogs or delivery systems that can increase its stability and reduce its toxicity.

[[Category:Antimicrobial peptides]]
[[Category:Porcine]]
[[Category:Cathelicidin]]
[[Category:Bacterial infections]]
[[Category:Antibiotics]]
[[Category:Gram-positive bacteria]]
[[Category:Gram-negative bacteria]]
[[Category:Fungi]]

{{stub}}

Protegrin - Revision history

Prab: CSV import

Prab: CSV import